Stocks and InvestingStocks and Investing
Thu, October 28, 2021
Wed, October 27, 2021
Tue, October 26, 2021
Mon, October 25, 2021

Anupam Rama Upgraded (VIR) to Hold and Increased Target to $37 on, Oct 25th, 2021


Published on 2024-10-27 18:18:13 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Upgraded "Vir Biotechnology, Inc." (VIR) to Hold and Increased Target from $29 to $37 on, Oct 25th, 2021.

Anupam has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Wednesday, September 22nd, 2021


This is the rating of the analyst that currently disagrees with Anupam


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021